Circadian variations of ischemic burden among patients with myocardial infarction undergoing primary percutaneous

Stephane Fournier1, Eric Eeckhout, Fabio Mangiacapra

  • 1Cardiology, University Hospital Center, Lausanne, Switzerland.

American Heart Journal
|February 7, 2012
PubMed

Insights

Patients experiencing ST-elevation myocardial infarction (STEMI) symptoms between midnight and 6 AM have larger infarct sizes and higher mortality. This suggests the time of day impacts STEMI outcomes.

Area of Science:

  • Cardiology
  • Circadian Rhythms
  • Myocardial Infarction

Background:

  • Cardiovascular physiology exhibits circadian rhythms.
  • Experimental models suggest infarct size correlates with time of day.
  • Investigating circadian influence on ischemic burden in STEMI patients is crucial.

Purpose of the Study:

  • To determine if circadian rhythms influence ischemic burden in ST-elevation myocardial infarction (STEMI) patients.
  • To assess the impact of symptom onset time on infarct size and outcomes in STEMI patients undergoing primary percutaneous coronary intervention (PPCI).

Main Methods:

  • 353 STEMI patients treated with PPCI were analyzed.
  • Symptom onset time, peak creatine kinase (CK), and 30-day mortality were recorded.
  • Patients were grouped into four 6-hour intervals based on symptom onset.

Main Results:

  • No significant differences in baseline characteristics or management were observed between groups.
  • Patients with symptom onset between 00:00-05:59 showed a 38.4% increase in peak CK levels (P < .05).
  • Thirty-day mortality was significantly higher for STEMI patients with symptom onset between 00:00-05:59 (P < .05).

Conclusions:

  • An independent correlation exists between STEMI infarct size, PPCI, and symptom onset time.
  • The time of day is a critical factor in assessing prognosis for myocardial infarction patients.
  • Circadian variations in physiological parameters may contribute to observed differences in STEMI outcomes.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...